Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

OptimizeRx Corp Director's Dealing 2015

Jan 27, 2015

33090_dirs_2015-01-27_b7a214fd-dbe1-4a49-95ee-514bea521f27.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2015-01-23

Reporting Person: Pinney Jack T (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-01-23 Common Stock A 6250 $1.09 Acquired 752079 Direct